HCA Healthcare (NYSE:HCA) Stock: Insider Jon Foster Sells 10,000 Shares

HCA Healthcare, Inc. (NYSE:HCA) COO Jon Foster sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $514.07, for a total value of $5,140,700.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

HCA Healthcare Stock Performance

HCA stock traded down $13.04 during trading on Friday, hitting $494.44. 1,462,203 shares of the company traded hands, compared to its average volume of 1,355,955. The company has a 50-day moving average of $442.16 and a 200-day moving average of $445.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The firm has a market capitalization of $103.28 billion, a PE ratio of 16.38, a P/E/G ratio of 1.71 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The business had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.96 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is currently 10.34%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. The Goldman Sachs Group cut their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. UBS Group dropped their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a report on Monday, July 27th. Weiss Ratings raised HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Finally, Leerink Partners reiterated an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a report on Friday, September 18th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $480.13.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Money Concepts Capital Corp grew its holdings in HCA Healthcare by 6.7% in the third quarter. Money Concepts Capital Corp now owns 719 shares of the company’s stock worth $307,000 after purchasing an additional 45 shares during the period. Allworth Financial LP boosted its position in shares of HCA Healthcare by 8.7% in the 3rd quarter. Allworth Financial LP now owns 1,246 shares of the company’s stock worth $486,000 after purchasing an additional 100 shares in the last quarter. Russell Investments Group Ltd. grew its stake in shares of HCA Healthcare by 23.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 653,234 shares of the company’s stock worth $278,823,000 after buying an additional 122,894 shares during the last quarter. Maryland State Retirement & Pension System increased its position in HCA Healthcare by 10.8% during the 3rd quarter. Maryland State Retirement & Pension System now owns 8,951 shares of the company’s stock valued at $3,820,000 after buying an additional 871 shares in the last quarter. Finally, Ritholtz Wealth Management raised its stake in HCA Healthcare by 6.7% during the third quarter. Ritholtz Wealth Management now owns 14,137 shares of the company’s stock valued at $6,033,000 after buying an additional 883 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.